Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06571747
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-22
Brief Title:
Kaiser Permanente VACCination Improvement with Nudge-based CardiovAscular Targeted Engagement
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Kaiser Permanente VACCination Improvement with Nudge-based CardiovAscular Targeted Engagement
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
KP-VACCINATE
Brief Summary:
In randomized clinical trials and observational studies influenza vaccination is effective in reducing influenza-related illness and hospitalizations and potentially cardiovascular CV events and mortality in select populations However the potential population-level benefit of influenza vaccination is limited by its uptake Novel implementation strategies to improve vaccination uptake are needed
KP VACCINATE is a multicenter sequential individual-level randomized controlled implementation trial examining the effectiveness of a CV-focused nudging communication vs usual care communication on influenza vaccination uptake among Kaiser Permanente Northern California KPNC and Kaiser Permanente Mid Atlantic States KPMAS eligible members during the 2024-2025 influenza season
KP VACCINATE is a multicenter sequential individual-level randomized controlled implementation trial examining the effectiveness of a CV-focused nudging communication vs usual care communication on influenza vaccination uptake among Kaiser Permanente Northern California KPNC and Kaiser Permanente Mid Atlantic States KPMAS eligible members during the 2024-2025 influenza season
Detailed Description:
In randomized clinical trials and observational studies influenza vaccination is effective in reducing influenza-related illness and hospitalizations and potentially cardiovascular events and mortality in select populations However the potential population level benefit of influenza vaccination is limited by its uptake Novel implementation strategies to improve vaccination uptake are needed
KP VACCINATE is a multicenter sequential individual-level randomized controlled implementation trial examining the effectiveness of a CV-focused nudging communication vs usual care communication on influenza vaccination uptake among Kaiser Permanente Northern California KPNC and Kaiser Permanente Mid Atlantic States KPMAS eligible members during the 2024-2025 influenza season
The study will evaluate an operational directive at KPNC and KPMAS Eligible participants will be randomized into 4 study arms corresponding to the messaging received at two different vaccine communication touchpoints Touchpoint 1Touchpoint 2 during the 2024-2025 influenza season
1 CV-focused nudge communicationCV-focused nudge communication
2 CV-focused nudge communicationUsual care communication
3 Usual care communicationCV-focused nudge communication
4 Usual care communicationUsual care communication
KP VACCINATE is a multicenter sequential individual-level randomized controlled implementation trial examining the effectiveness of a CV-focused nudging communication vs usual care communication on influenza vaccination uptake among Kaiser Permanente Northern California KPNC and Kaiser Permanente Mid Atlantic States KPMAS eligible members during the 2024-2025 influenza season
The study will evaluate an operational directive at KPNC and KPMAS Eligible participants will be randomized into 4 study arms corresponding to the messaging received at two different vaccine communication touchpoints Touchpoint 1Touchpoint 2 during the 2024-2025 influenza season
1 CV-focused nudge communicationCV-focused nudge communication
2 CV-focused nudge communicationUsual care communication
3 Usual care communicationCV-focused nudge communication
4 Usual care communicationUsual care communication
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None